Skip Navigation

Cardiovascular Research 2007 75(1):40-50; doi:10.1016/j.cardiores.2007.03.027
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Schneider, M.
Right arrow Articles by Sheikh, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schneider, M.
Right arrow Articles by Sheikh, S. P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2007, European Society of Cardiology

S100A4 is upregulated in injured myocardium and promotes growth and survival of cardiac myocytes

Mikael Schneidera,1, Sawa Kostinb, Claes C. Strøma, Mark Aplina, Stig Lyngbæka, Juliane Theiladea, Mariam Grigorianc, Claus B. Andersend, Eugene Lukanidinc, Jakob Lerche Hansena and Søren P. Sheikha,*,1

aThe Laboratory of Molecular and Cellular Cardiology, The Danish National Research Foundation Centre for Cardiac Arrhythmia, Department of Medicine B, H:S Rigshospitalet, Copenhagen University Hospital, Denmark
bMax-Planck-Institute for Heart and Lung Research, Bad Nauheim, Germany
cDepartment of Molecular Cancer Biology, Danish Cancer Society, Denmark
dDepartment of Pathology, H:S Rigshospitalet, Copenhagen University Hospital, Denmark

* Corresponding author. Laboratory of Molecular Cardiology, Department of Biochemistry, Pharmacology, and Genetics, University Hospital of Odense, 29, Sdr. Boulevard, DK 5000 Odense, Denmark. Tel.: +45 65414468; fax: +45 65411911. sheikh{at}dadlnet.dk

Objective The multifunctional Ca2+-binding protein S100A4 (also known as Mts1 and Fsp1) is involved in fibrosis and tissue remodeling in several diseases including cancer, kidney fibrosis, central nervous system injury, and pulmonary vascular disease. We previously reported that S100A4 mRNA expression was increased in hypertrophic rat hearts and that it has pro-cardiomyogenic effects in embryonic stem cell-derived embryoid bodies. We therefore hypothesized that S100A4 could play a supportive role in the injured heart.

Methods and results Here we verify by quantitative real-time PCR and immunoblotting that S100A4 mRNA and protein is upregulated in hypertrophic rat and human hearts and show by way of confocal microscopy that S100A4 protein, but not mRNA, appears in cardiac myocytes only in the border zone after an acute ischemic event in rat and human hearts. In normal rat and human hearts, S100A4 expression primarily colocalizes with markers of fibroblasts. In hypertrophy elicited by aortic banding/stenosis or myocardial infarction, this expression is increased. Moreover, invading macrophages and leucocytes stain strongly for S100A4, further increasing cardiac levels of S100A4 protein after injury. Promisingly, recombinant S100A4 protein elicited a robust hypertrophic response and increased the number of viable cells in cardiac myocyte cultures by inhibiting apoptosis. We also found that ERK1/2 activation was necessary for both the hypertrophy and survival effects of S100A4 in vitro.

Conclusions Along with proposed angiogenic and cell motility stimulating effects of S100A4, these findings suggest that S100A4 can act as a novel cardiac growth and survival factor and may have regenerative effects in injured myocardium.

KEYWORDS S100A4/Mts1; Cardiac hypertrophy; Myocardial infarction; Cardiac myocytes; Apoptosis; Cardioprotection

1 Present address: Department of Biochemistry, Pharmacology, and Genetics, University Hospital of Odense, Denmark.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.